Healthcare & life sciences · Life-sciences companies and their backers
A value-chain map of the market, the companies at each stage and the gaps, with a ranked shortlist on your criteria.
Sourced answers in days, not months: AI research, analyst-checked.
Discuss your projectSee an example ↓Explore research services ↓What you gain
The stages, the companies at each and where the margins sit.
Stages with too few suppliers, and what each gap is worth.
A ranked shortlist, with the evidence beside every score.
Example deliverable
In one national market, domestic drug manufacturing met under a tenth of drug spending. A stage map shows where the gaps sit.
Most active ingredients are imported, and sterile fill-finish is short of capacity: the two gaps worth a closer look.
| Stage | Companies | Domestic share of supply% | Gap |
|---|---|---|---|
| Active ingredients | 4 | 10 | Most supply imported |
| Formulation and fill-finish | 12 | 35 | Short of sterile capacity |
| Packaging and labelling | 20 | 60 | None |
| Distribution | 8 | 80 | None |
| Rounded. Example source · as of an example date. | |||
Recent work · anonymized
Research services
Start with one question
Name the market and your criteria. We start with a first map and go deeper where the gaps are.
